4//SEC Filing
Konidaris Tasos 4
Accession 0001628280-25-010115
CIK 0001723128other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:59 PM ET
Size
8.8 KB
Accession
0001628280-25-010115
Insider Transaction Report
Form 4
Konidaris Tasos
Executive Vice President & CFO
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-01−36,197→ 0 total→ Class A Common Stock (36,197 underlying) - Tax Payment
Class A Common Stock
2025-03-01$8.67/sh−13,494$116,993→ 550,019 total - Exercise/Conversion
Class A Common Stock
2025-03-01+36,197→ 563,513 total
Footnotes (4)
- [F1]Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F3]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
- [F4]On March 1, 2021, the reporting person was granted 144,788 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001320982
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:59 PM ET
- Size
- 8.8 KB